Skip to main content
Premium Trial:

Request an Annual Quote

NCI Takes Site-Wide License to Partek Genomic Suite

NEW YORK (GenomeWeb News) - The National Cancer Institute has purchased site-wide licenses to Partek’s Genomic Suite, the company announced today.
 
The suite is a statistical and visual data analysis software package that can handle thousands of samples and millions of variables in a genomics experiment, according to Partek.
 
Financial terms of the deal were not released.
 
Every researcher at NCI will have access to the suite as a result of the transaction, the company said.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.